Early stage IT and Healthcare Investing



company snapshot


Fluidigm is a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Its technology enables the rapid, efficient, highly parallel, and reproducible analysis of tens to hundreds of genetic markers across hundreds or thousands of DNA samples in hours instead of days or weeks. The company went public in 2011.

Investment Team
Gajus Worthington, President, CEO & Co-Founder
Facebook Google+ Twitter Email LinkedIn Share